Directed Walk Designs for Dose-Response Problems with Competing Failure Modes
dc.contributor.author | Hardwick, Janis | en_US |
dc.contributor.author | Meyer, Mary C. | en_US |
dc.contributor.author | Stout, Quentin F. | en_US |
dc.date.accessioned | 2010-04-01T15:40:24Z | |
dc.date.available | 2010-04-01T15:40:24Z | |
dc.date.issued | 2003-06 | en_US |
dc.identifier.citation | Hardwick, Janis; Meyer, Mary C.; Stout, Quentin F. (2003). "Directed Walk Designs for Dose-Response Problems with Competing Failure Modes." Biometrics 59(2): 229-236. <http://hdl.handle.net/2027.42/66162> | en_US |
dc.identifier.issn | 0006-341X | en_US |
dc.identifier.issn | 1541-0420 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/66162 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12926707&dopt=citation | en_US |
dc.description.abstract | We examine adaptive allocation designs for the problem of determining the optimal therapeutic dose for subjects in early-phase clinical trials. A subject can fail due to lack of efficacy or due to a toxic reaction. Successful subjects will have both a positive response and no toxic side effects. Thus, we seek to maximize the product of the nontoxicity and efficacy dose-response curves. We are interested in sampling rules that perform well along several criteria, including the ethical criterion that, as often as possible, experimental subjects be treated at or close to the maximum in question. Statistically, we wish to identify the optimum dose with high probability at the close of the experiment. Here, we propose designs that combine new allocation policies, directed walks, with new smoothed shape-constrained curve-fitting techniques. These are compared with a variety of other curve-fitting techniques and with up-and-down and equal allocation rules. | en_US |
dc.format.extent | 172770 bytes | |
dc.format.extent | 3110 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing | en_US |
dc.rights | The International Biometric Society, 2003 | en_US |
dc.subject.other | Bayesian | en_US |
dc.subject.other | Convex-concave | en_US |
dc.subject.other | CRM | en_US |
dc.subject.other | Efficiency | en_US |
dc.subject.other | Experimental Design | en_US |
dc.subject.other | Isotonic | en_US |
dc.subject.other | Nonparametric | en_US |
dc.subject.other | Phase I/II | en_US |
dc.subject.other | Random Walk | en_US |
dc.subject.other | Sequential | en_US |
dc.subject.other | Unimodal | en_US |
dc.title | Directed Walk Designs for Dose-Response Problems with Competing Failure Modes | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Mathematics | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | EECS Department, University of Michigan, Ann Arbor, Michigan 48109, U.S.A. | en_US |
dc.contributor.affiliationother | Statistics Department, University of Georgia, Athens, Georgia 30602, U.S.A. | en_US |
dc.identifier.pmid | 12926707 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/66162/1/1541-0420.00029.pdf | |
dc.identifier.doi | 10.1111/1541-0420.00029 | en_US |
dc.identifier.source | Biometrics | en_US |
dc.identifier.citedreference | Bryant, J. and Day, R. ( 1995 ). Incorporating toxicity considerations into the design of two-stage phase II clinical trials. Biometrics 51, 1372 – 1383. | en_US |
dc.identifier.citedreference | Conaway, M. R. and Petroni, G. R. ( 1996 ). Designs for phase II trials allowing for a trade-off between response and toxicity. Biometrics 52, 1375 – 1386. | en_US |
dc.identifier.citedreference | Gooley, T. A., Martin, P. J., Fisher, L. D., and Pettinger, M. ( 1994 ). Simulation as a design tool for phase I/II clinical trials—An example from bone-marrow transplantation. Controlled Clinical Trials 15, 450 – 462. | en_US |
dc.identifier.citedreference | Hardwick, J. and Stout, Q. F. ( 2001 ). Optimizing a unimodal response function for binary variables. In Optimum Design 2000, A. Atkinson, B. Bogacka, and A. Zhigljavsky ( eds ), 195 – 210. Dordrecht : Kluwer. | en_US |
dc.identifier.citedreference | Hardwick, J., Oehmke, R., and Stout, Q. F. ( 2001 ). Optimal adaptive designs for delayed response models: Exponential case. In MODA 6: Advances in Model Oriented Design and Analysis, A. Atkinson, P. Hackl, and W. MÜeller ( eds ), 127 – 134. Heidelberg : Physica Verlag. | en_US |
dc.identifier.citedreference | Jennison, C. and Turnbull, B. ( 1993 ). Group sequential tests for bivariate response—Interim analyses of clinical-trials with both efficacy and safety end-points. Biometrics 49, 741 – 752. | en_US |
dc.identifier.citedreference | Kpamegan, E. E. and Flournoy, N. ( 2001 ). An optimizing up-and-down design. In Optimum Design 2000, A. Atkinson, B. Bogacka, and A. Zhigljavsky ( eds ), 211 – 224. Dordrecht : Kluwer. | en_US |
dc.identifier.citedreference | Li, Y., Durham, S., and Flournoy, N. ( 1995 ). An adaptive design for maximization of a contingent binary response. In Adaptive Designs, B. Rosenberger and N. Flournoy ( eds ), Institute of Mathematical Statistics Lecture Notes 25, 179 – 196. | en_US |
dc.identifier.citedreference | Meyer, M. ( 1999 ). A comparison of nonparametric shape constrained bioassay estimators. Statistics and Probability Letters 42, 267 – 274. | en_US |
dc.identifier.citedreference | Meyer, M. and Laud, P. ( 2002 ). Predictive variable selection in generalized linear models. Journal of the American Statistical Association 97, 859 – 871. | en_US |
dc.identifier.citedreference | Murtaugh, P. A. and Fisher, L. D. ( 1990 ). Bivariate binary models of efficacy and toxicity in dose-ranging trials. Communications in Statistics—Theory and Methods 19, 2003 – 2020. | en_US |
dc.identifier.citedreference | O'Quigley, J., Pepe, M., and Fisher, L. ( 1990 ). Continual reassessment method: A practical design for phase I clinical trials in cancer. Biometrics 46, 33 – 48. | en_US |
dc.identifier.citedreference | O'Quigley, J., Hughes, M., and Fenton, T. ( 2001 ). Dose-finding designs for HIV studies. Biometrics 57, 1018 – 1029. | en_US |
dc.identifier.citedreference | Thall, P. F. and Russell, K. E. ( 1998 ). A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trials. Biometrics 54, 251 – 264. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.